Pfizer Secures FDA Approval for Hemophilia B Gene Therapy, Launches Warranty
Pictured: Entrance to Pfizer's office in Belgium/iStock, Alexandros Michailidis The FDA on Friday gave its approval to Pfizer’s one-time gene therapy fidanacogene elaparvovec-dzkt, which will now carry the brand name Beqvez, for the treatment of …